Nightingale HIGH CBD

Nightingale is a high-CBD cultivar developed by combining Harlitsu genetics with a West Coast variety. This strain delivers a distinctive taste profile featuring grape, blueberry, and jasmine notes. Bred to emphasize cannabidiol content ranging from 11-18% while keeping tetrahydrocannabinol to just 1-3%, Nightingale serves users across the lifespan, including very young children and senior adults.

The plant produces generous harvests and typically develops red or purple-tinted flower clusters. Growers should anticipate significant vertical growth, making this variety particularly well-suited to Screen of Green and Sea of Green cultivation methods. From a therapeutic perspective, this strain has shown promise for managing Crohn's Disease, Epilepsy, Arthritis, Cancer, and various immune-related ailments.